The Role of Gamma Zone Peripapillary Atrophy in Diabetic Retinopathy
Author Information
Author(s): Li Yingying, Hu Xinxin, Ye Xueqiong, Zhong Qingya, Zhang Xixi, Zhu Jinglin, Jiang Jiahui, Wang Dandan, Zhang Juntao, Ren Weina, Zhao Yitian, Lu Qinkang, Zhao Na
Primary Institution: The Affiliated People’s Hospital of Ningbo University
Hypothesis
Does gamma zone peripapillary atrophy (PPA) reduce the risk of diabetic retinopathy (DR) in patients with type 2 diabetes?
Conclusion
Gamma zone PPA is associated with a reduced risk of developing diabetic retinopathy.
Supporting Evidence
- Gamma zone PPA was linked to lower diabetic retinopathy grades independent of other risk factors.
- Participants with isolated gamma zone PPA had significantly lower odds of developing diabetic retinopathy.
- Beta zone PPA was associated with older age but did not correlate with reduced DR odds.
Takeaway
This study found that having a specific type of eye change called gamma zone PPA can help protect against a serious eye problem called diabetic retinopathy in people with diabetes.
Methodology
This cross-sectional study involved 845 patients with type 2 diabetes who underwent detailed evaluations and imaging to assess the relationship between PPA and DR.
Potential Biases
Potential for bias due to the cross-sectional nature of the study and the small sample size for certain subgroups.
Limitations
The cross-sectional design limits the ability to assess DR progression over time, and the small subgroup of isolated gamma zone changes may introduce statistical bias.
Participant Demographics
Mean age of participants was 66 years, with 51.7% male.
Statistical Information
P-Value
p<0.001
Confidence Interval
0.200 (0.099, 0.404)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website